These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 26908717)
41. World Health Organization's Innovative Direct Disbursement Mechanism for Payment of Grassroots Immunization Personnel and Operations in Nigeria: 2004-2015. Yehualashet YG; Wadda A; Agblewonu KB; Zhema T; Ibrahim AA; Corr A; Linkins J; Mkanda P; Vaz RG; Nsubuga P; Ashogbon D J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S108-15. PubMed ID: 26908746 [TBL] [Abstract][Full Text] [Related]
42. Conflict and polio: winning the polio wars. Bhutta ZA JAMA; 2013 Sep; 310(9):905-6. PubMed ID: 24002271 [No Abstract] [Full Text] [Related]
43. A survey for neutralizing antibodies to the three types of poliovirus among children in Maiduguri, Nigeria. Baba MM; Haruna BA; Ogunmola O; Ambe JP; Shidali NN; Oderinde B; Marcello A; Talle M J Med Virol; 2012 Apr; 84(4):691-6. PubMed ID: 22337311 [TBL] [Abstract][Full Text] [Related]
44. The global eradication of poliomyelitis: progress and problems. Rey M; Girard MP Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):317-25. PubMed ID: 17923156 [TBL] [Abstract][Full Text] [Related]
45. Lessons learnt from implementing community engagement interventions in mobile hard-to-reach (HTR) projects in Nigeria, 2014-2015. Hammanyero KI; Bawa S; Braka F; Bassey BE; Fatiregun A; Warigon C; Yehualashet YG; Tegene SG; Banda R; Korir C; Erbeto TB; Chukwuji M; Mkanda P; Adamu US; Nsubuga P BMC Public Health; 2018 Dec; 18(Suppl 4):1306. PubMed ID: 30541514 [TBL] [Abstract][Full Text] [Related]
46. Continued Endemic Wild Poliovirus Transmission in Security-Compromised Areas - Nigeria, 2016. Nnadi C; Damisa E; Esapa L; Braka F; Waziri N; Siddique A; Jorba J; Nganda GW; Ohuabunwo C; Bolu O; Wiesen E; Adamu U MMWR Morb Mortal Wkly Rep; 2017 Feb; 66(7):190-193. PubMed ID: 28233765 [TBL] [Abstract][Full Text] [Related]
47. Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial. Habib MA; Soofi S; Cousens S; Anwar S; Haque NU; Ahmed I; Ali N; Tahir R; Bhutta ZA Lancet Glob Health; 2017 Jun; 5(6):e593-e603. PubMed ID: 28495264 [TBL] [Abstract][Full Text] [Related]
49. Perspectives on polio and immunization in Northern Nigeria. Renne E Soc Sci Med; 2006 Oct; 63(7):1857-69. PubMed ID: 16765498 [TBL] [Abstract][Full Text] [Related]
50. Transboundary nomadic population movement: a potential for import-export of poliovirus. Bawa S; Afolabi M; Abdelrahim K; Abba G; Ningi A; Tafida SY; Tegegne SG; Warigon C; Nomhwange T; Umar SA; Aregay A; Fanti A; Ahmed B; Nsubuga P; Adamu U; Braka F; Wondimagegnehu A; Shuaib F BMC Public Health; 2018 Dec; 18(Suppl 4):1316. PubMed ID: 30541502 [TBL] [Abstract][Full Text] [Related]
51. Historical reconstruction of inaccessibility status in Local Government Areas (LGAs) of Borno and Yobe States, Nigeria, 2010-2020. Forbi JC; Musa MS; Salawu M; Idris JM; Ba'aba AI; Higgins J; Musa AI; Bashir B; Shettima A; Njeakor N; Uzoma I; Mshelia H; Nganda GW; Mohammed KI; Bomoi IM; Chiroma U; Kovacs SD; Biya O; Waziri NE; Aina M; Adamu US; Shuaib F; Bolu O; Franka R; Wiesen E Pan Afr Med J; 2023; 45(Suppl 2):7. PubMed ID: 38370102 [TBL] [Abstract][Full Text] [Related]
53. Mass immunization campaign launched to protect 15 million children from polio, as outbreak in Nigeria spreads across West Africa. Can Commun Dis Rep; 2004 Jan; 30(1):7-8. PubMed ID: 14964084 [No Abstract] [Full Text] [Related]
55. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708 [TBL] [Abstract][Full Text] [Related]
56. Sabin and wild polioviruses from apparently healthy primary school children in northeastern Nigeria. Baba MM; Oderinde BS; Patrick PZ; Jarmai MM J Med Virol; 2012 Feb; 84(2):358-64. PubMed ID: 22170559 [TBL] [Abstract][Full Text] [Related]
57. Key issues in the persistence of poliomyelitis in Nigeria: a case-control study. Mangal TD; Aylward RB; Mwanza M; Gasasira A; Abanida E; Pate MA; Grassly NC Lancet Glob Health; 2014 Feb; 2(2):e90-7. PubMed ID: 25104665 [TBL] [Abstract][Full Text] [Related]
58. Polio supplementary immunization activities and equity in access to vaccination: evidence from the demographic and health surveys. Helleringer S; Abdelwahab J; Vandenent M J Infect Dis; 2014 Nov; 210 Suppl 1():S531-9. PubMed ID: 25316877 [TBL] [Abstract][Full Text] [Related]
59. Improving polio vaccination coverage in Nigeria through the use of geographic information system technology. Barau I; Zubairu M; Mwanza MN; Seaman VY J Infect Dis; 2014 Nov; 210 Suppl 1():S102-10. PubMed ID: 25316823 [TBL] [Abstract][Full Text] [Related]
60. The Potential Contribution of Supplementary Immunization Activities to Routine Immunization in Kebbi State, Nigeria. Omoleke SA; Getachew B; Igoh CS; Yusuf TA; Lukman SA; Loveday N J Prim Care Community Health; 2020; 11():2150132720932698. PubMed ID: 32508212 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]